Working… Menu
Trial record 46 of 466 for:    Inherited Bleeding Disorder

Gene Therapy Study in Severe Haemophilia A Patients With Antibodies Against AAV5 (270-203)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03520712
Recruitment Status : Enrolling by invitation
First Posted : May 10, 2018
Last Update Posted : April 8, 2019
Information provided by (Responsible Party):
BioMarin Pharmaceutical

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : June 2024
Estimated Study Completion Date : June 2024